Schwartz Investment Counsel’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $27.8M | Sell |
372,500
-2,000
| -0.5% | -$149K | 0.92% | 42 |
|
2025
Q1 | $23.8M | Buy |
374,500
+223,500
| +148% | +$14.2M | 0.82% | 40 |
|
2024
Q4 | $11.8M | Hold |
151,000
| – | – | 0.42% | 63 |
|
2024
Q3 | $12.1M | Hold |
151,000
| – | – | 0.43% | 65 |
|
2024
Q2 | $12.5M | Hold |
151,000
| – | – | 0.46% | 62 |
|
2024
Q1 | $12.9M | Buy |
151,000
+32,000
| +27% | +$2.73M | 0.47% | 57 |
|
2023
Q4 | $10.2M | Hold |
119,000
| – | – | 0.4% | 68 |
|
2023
Q3 | $10.7M | Sell |
119,000
-40,000
| -25% | -$3.58M | 0.46% | 64 |
|
2023
Q2 | $13.5M | Hold |
159,000
| – | – | 0.57% | 50 |
|
2023
Q1 | $13.2M | Sell |
159,000
-25,000
| -14% | -$2.07M | 0.58% | 50 |
|
2022
Q4 | $14.5M | Hold |
184,000
| – | – | 0.66% | 47 |
|
2022
Q3 | $13.6M | Sell |
184,000
-5,000
| -3% | -$370K | 0.7% | 44 |
|
2022
Q2 | $12.3M | Hold |
189,000
| – | – | 0.6% | 47 |
|
2022
Q1 | $11.9M | Buy |
189,000
+51,000
| +37% | +$3.22M | 0.5% | 51 |
|
2021
Q4 | $7.32M | Buy |
138,000
+28,000
| +25% | +$1.49M | 0.28% | 62 |
|
2021
Q3 | $7.77M | Buy |
110,000
+20,000
| +22% | +$1.41M | 0.32% | 58 |
|
2021
Q2 | $6M | Buy |
90,000
+30,000
| +50% | +$2M | 0.24% | 69 |
|
2021
Q1 | $6.66M | Hold |
60,000
| – | – | 0.29% | 59 |
|
2020
Q4 | $7.13M | Buy |
60,000
+10,000
| +20% | +$1.19M | 0.32% | 58 |
|
2020
Q3 | $4.36M | Buy |
50,000
+25,000
| +100% | +$2.18M | 0.22% | 66 |
|
2020
Q2 | $2.24M | Buy |
+25,000
| New | +$2.24M | 0.12% | 77 |
|